Diane Glendinning
Acute Care · Little Rock, ARNPI 1710253612
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $18,615 of the $26,196 with a category attached, or 71.1%. Johnson & Johnson accounts for 93.5% of it on its own, with 39 other manufacturers making up the rest. 2025 is the largest year on record at $24,182, more than ten times the $429 reported in 2021. Among acute care clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 158 payments — averaging $165.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$24K
- Janssen Scientific Affairs, LLC$193
- Bristol Myers Squibb$156
- Novartis$130
- Sanofi-aventis U.S. LLC$117
- Sanofi$100
- plus $1K from 34 others
What the payments were for
- Consulting fees$8703%
- Speaking & faculty fees$18,61571%
- Travel & lodging$3,56014%
- Food & beverage$2,75611%
- Education$3952%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,196 in reported general payments places this provider in the 95th percentile of 321 acute care providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 14 | $1,015 |
| Acyclovir | 27 | $445 |
| Dexamethasone | 12 | $199 |
| Doxycycline Hyclate | 15 | $195 |
| Potassium Chloride | 13 | $116 |
| Ondansetron OdtOndansetron | 12 | $116 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $80 |
| Levofloxacin | 23 | $72 |
| Prednisone | 13 | $68 |
| Omeprazole | 19 | $67 |
| Allopurinol | 13 | $38 |
Paid to pharmacies, not to this prescriber.
Other acute care in Little Rock
- Jill AveryLittle Rock$117K
- Lynn FrazierLittle Rock$106K
- Beverly BaxterLittle Rock$95K
- Beth CrowderLittle Rock$25K
- Carmen Paniagua TorresLittle Rock$21K
- Shana KloskeLittle Rock$14K
- Debra BrentLittle Rock$9K
- Ginger HartLittle Rock$9K
- Holly TrottaLittle Rock$7K
- Katelyn LomaxLittle Rock$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.